Trial Profile

Clinical Protocol for Administration of Topical Pentoxifylline Gel on Behcet's Disease Oral Ulcers

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pentoxifylline (Primary) ; Colchicine
Indications Behcet's syndrome; Oral ulcer
Focus Proof of concept; Therapeutic Use

Most Recent Events

01 May 2023 Results presented in a Soligenix Inc. media release.
01 May 2023 According to a Soligenix Inc. media release, company today announced that it has entered into an exclusive option agreement with Silk Road Therapeutics. The option agreement grants the Company the right to acquire a novel topical formulation of Pentoxifylline, for the treatment of mucocutaneous ulcers in patient's suffering from Behcet's Disease (BD).
05 Aug 2019 Planned End Date changed from 1 Jul 2019 to 1 Oct 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com